APA (7th ed.) Citation

Wu, R., Wang, X., Zhao, X., Cheng, Y., Zhou, Z., Sun, J., . . . Yang, R. (2022). Efficacy, safety and pharmacokinetics of recombinant human coagulation factor VIII (omfiloctocog alfa) in previously treated Chinese children with severe hemophilia A. Haemophilia, 28(6), e199. https://doi.org/10.1111/hae.14622

Chicago Style (17th ed.) Citation

Wu, Runhui, et al. "Efficacy, Safety and Pharmacokinetics of Recombinant Human Coagulation Factor VIII (omfiloctocog Alfa) in Previously Treated Chinese Children with Severe Hemophilia A." Haemophilia 28, no. 6 (2022): e199. https://doi.org/10.1111/hae.14622.

MLA (9th ed.) Citation

Wu, Runhui, et al. "Efficacy, Safety and Pharmacokinetics of Recombinant Human Coagulation Factor VIII (omfiloctocog Alfa) in Previously Treated Chinese Children with Severe Hemophilia A." Haemophilia, vol. 28, no. 6, 2022, p. e199, https://doi.org/10.1111/hae.14622.